Randomized trial characterizes microbubble dynamics under physiological flow, suggesting improved ultrasound imaging agents.
Variability in targeted microbubble binding experiments remains a major barrier to translating molecular ultrasound imaging agents, and existing in vitro platforms are costly, slow to fabricate, or poorly suited to surface functionalization. This work presents a low-cost microfluidic imaging platform that integrates laser-cut flow channels, high-speed brightfield microscopy, and automated video analysis to characterize microbubble dynamics under physiological flow. Microfluidic chips were fabricated by thermally bonding laser-cut Parafilm gaskets between glass slides and acrylic manifolds. Three channel sizes spanning vascular dimensions (216–1067 μm width, 120 μm depth) were produced with width variability below 3%. Microbubble flow was captured at up to 24,000 fps and processed through an automated tracking pipeline that measured per-bubble velocity, size, and position. Measured velocity profiles reproduced the parabolic distribution predicted by laminar flow theory (R^2 = 0.98), and the system resolved individual bubbles at concentrations spanning two orders of magnitude. The glass substrate supports established functionalization chemistries for future targeted-adhesion assays. This platform provides a validated, rapidly iterable benchtop tool for screening microbubble formulations prior to in vivo studies.
No takes yet. Share an insight, caveat, or question.
Jacob Rose (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: